CD274 and neoplasm: Therefore, we summarize the previous regulatory mechanisms of PD-1/PD-L1 expression in tumors, and on this basis, look forward to the application prospects of tumor immunotherapy targeting the PD-1/PD-L1 axis, which could contribute to exploring new therapies for tumor immunity.